JPRN-UMIN000028845招募中2 期
HLA-haploidentical stem cell transplantation using a low dose ATG and steroid - HLA-haploidentical RIST
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. A history of adverse events for agents used in the conditioning treatment or GVHD prophylaxis. 2. Active CNS disorders other than leukemia. 3. Active infection. 4. Doctor's decision that patients are inappropriate for this study in some reasons.
研究者
相似试验
已完成
1 期
HLA haploidentical stem cell transplantation using myeloablative regimen including ATGhematologic malignanciesJPRN-UMIN000004904Hyogo College of Medicine20
已完成
不适用
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic diseasesAcute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Secondary acute myelogenous leukemia Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000002069Hematology, Osaka City University, Graduate School of Medicine17
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic malignancies (OCU13-3)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000011293Osaka City University35
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for Adult T-cell leukemia/lymphoma (ATL/L) and refractory aggressive lymphomaAdult T-cell leukemia/lymphoma (acute type and lymphoma type) Malignant lymphoma (aggressive hodgkin and non-hodgkin lymphoma)JPRN-UMIN000002606Hematology, Osaka City University, Graduate School of Medicine17
已完成
1 期
Allogeneic stem cell transplantation from HLA completely mismatched family donor for posttransplant relapsehematologic malignancies relapesd after allogeneic stem cell transplantationJPRN-UMIN000008117Hyogo College of Medicine20